205 related articles for article (PubMed ID: 35599475)
1. The value of contrast-enhanced ultrasound in the diagnosis of BI-RADS-US 4a lesions less than 2 cm in diameter.
Yu MQ; Zhang LL; Jiang LP; Zhou AY
Clin Hemorheol Microcirc; 2023; 83(3):195-205. PubMed ID: 35599475
[TBL] [Abstract][Full Text] [Related]
2. Predictive value of contrast-enhanced ultrasonography and ultrasound elastography for management of BI-RADS category 4 nonpalpable breast masses.
Niu Q; Zhao L; Wang R; Du L; Shi Q; Jia C; Li G; Jin L; Li F
Eur J Radiol; 2024 Apr; 173():111391. PubMed ID: 38422608
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic value of contrast-enhanced ultrasound in breast lesions of BI-RADS 4].
Liang YC; Jia CM; Xue Y; Lü Q; Chen F; Wang JJ
Zhonghua Yi Xue Za Zhi; 2018 May; 98(19):1498-1502. PubMed ID: 29804418
[No Abstract] [Full Text] [Related]
4. Application of contrast-enhanced ultrasound in the diagnosis of small breast lesions.
Du YR; Wu Y; Chen M; Gu XG
Clin Hemorheol Microcirc; 2018; 70(3):291-300. PubMed ID: 29710688
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis of Benign and Malignant BI-RADS 4 Breast Masses by Contrastenhanced Ultrasound Combined with Shear Wave Elastography.
Weng L; Yu M
Curr Med Imaging; 2023 Oct; ():. PubMed ID: 37921152
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of sub-centimetre breast lesions: combining BI-RADS-US with strain elastography and contrast-enhanced ultrasound-a preliminary study in China.
Xiao X; Jiang Q; Wu H; Guan X; Qin W; Luo B
Eur Radiol; 2017 Jun; 27(6):2443-2450. PubMed ID: 27761708
[TBL] [Abstract][Full Text] [Related]
7. The role of contrast-enhanced ultrasound in the diagnosis of malignant non-mass breast lesions and exploration of diagnostic criteria.
Zhang F; Jin L; Li G; Jia C; Shi Q; Du L; Wu R
Br J Radiol; 2021 Apr; 94(1120):20200880. PubMed ID: 33560894
[TBL] [Abstract][Full Text] [Related]
8. Application of Deep Learning to Reduce the Rate of Malignancy Among BI-RADS 4A Breast Lesions Based on Ultrasonography.
Zhao Z; Hou S; Li S; Sheng D; Liu Q; Chang C; Chen J; Li J
Ultrasound Med Biol; 2022 Nov; 48(11):2267-2275. PubMed ID: 36055860
[TBL] [Abstract][Full Text] [Related]
9. Breast non-mass-like lesions on contrast-enhanced ultrasonography: Feature analysis, breast image reporting and data system classification assessment.
Xu P; Yang M; Liu Y; Li YP; Zhang H; Shao GR
World J Clin Cases; 2020 Feb; 8(4):700-712. PubMed ID: 32149054
[TBL] [Abstract][Full Text] [Related]
10. Contrast-enhanced ultrasound to predict malignant upgrading of atypical ductal hyperplasia.
Li JK; Jin ZY; Xu YJ; Fu NQ; Jiang Y; Li SY; Niu RL; Liu G; Wang ZL
Breast Cancer Res; 2024 Feb; 26(1):27. PubMed ID: 38347651
[TBL] [Abstract][Full Text] [Related]
11. Incorporating Contrast-Enhanced Ultrasound into the BI-RADS Scoring System Improves Accuracy in Breast Tumor Diagnosis: A Preliminary Study in China.
Xiao X; Dong L; Jiang Q; Guan X; Wu H; Luo B
Ultrasound Med Biol; 2016 Nov; 42(11):2630-2638. PubMed ID: 27544439
[TBL] [Abstract][Full Text] [Related]
12. A Prospective Study on the Value of Ultrasound Microflow Assessment to Distinguish Malignant from Benign Solid Breast Masses: Association between Ultrasound Parameters and Histologic Microvessel Densities.
Park AY; Kwon M; Woo OH; Cho KR; Park EK; Cha SH; Song SE; Lee JH; Cha J; Son GS; Seo BK
Korean J Radiol; 2019 May; 20(5):759-772. PubMed ID: 30993927
[TBL] [Abstract][Full Text] [Related]
13. Value of contrast-enhanced ultrasound in the diagnosis of breast US-BI-RADS 3 and 4 lesions with calcifications.
Cheng M; Tong W; Luo J; Li M; Liang J; Pan F; Pan J; Zheng Y; Xie X
Clin Radiol; 2020 Dec; 75(12):934-941. PubMed ID: 32814625
[TBL] [Abstract][Full Text] [Related]
14. Does contrast-enhanced ultrasound (CEUS) play a better role in diagnosis of breast lesions with calcification? A comparison with MRI.
Pan J; Tong W; Luo J; Liang J; Pan F; Zheng Y; Xie X
Br J Radiol; 2020 Aug; 93(1112):20200195. PubMed ID: 32463295
[TBL] [Abstract][Full Text] [Related]
15. BI-RADS 4 breast lesions: could multi-mode ultrasound be helpful for their diagnosis?
Liu G; Zhang MK; He Y; Liu Y; Li XR; Wang ZL
Gland Surg; 2019 Jun; 8(3):258-270. PubMed ID: 31328105
[TBL] [Abstract][Full Text] [Related]
16. Value of contrast-enhanced malignancy imaging features in secondary grade diagnosis of BI-RADS-US type 4 breast lesions.
Gao J; Han W; Ai Si Mu Tu La DLMT; Hou X; Li ZM; Song T
Tumori; 2021 Oct; 107(5):424-431. PubMed ID: 33124515
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of contrast-enhanced ultrasonography in breast ductal abnormalities.
Wang B; Yang D; Zhang X; Gong X; Xu T; Han J; Ren Y; Zou S; Li L; Wang Y
Cancer Imaging; 2023 Mar; 23(1):25. PubMed ID: 36899406
[TBL] [Abstract][Full Text] [Related]
18. Principal component regression-based contrast-enhanced ultrasound evaluation system for the management of BI-RADS US 4A breast masses: objective assistance for radiologists.
Lin ZM; Chen JF; Xu FT; Liu CM; Chen JS; Wang Y; Zhang C; Huang PT
Ultrasound Med Biol; 2021 Jul; 47(7):1737-1746. PubMed ID: 33838937
[TBL] [Abstract][Full Text] [Related]
19. The value of elastography strain rate ratio in benign and malignant BI-RADS-US 3-4 breast masses.
Li X; Sun W; Zhang H
Biomol Biomed; 2024 May; 24(3):625-632. PubMed ID: 38149832
[TBL] [Abstract][Full Text] [Related]
20. Value of inversion imaging to diagnosis in differentiating malignant from benign breast masses.
Li N; Hou Z; Wang J; Bi Y; Wu X; Zhan Y; Peng M
BMC Med Imaging; 2023 Dec; 23(1):206. PubMed ID: 38066441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
